Disclosures. Natural history 23/05/2018. Conflicts of interests: nil. PCOS: Developmental origin
|
|
- Jennifer Barton
- 5 years ago
- Views:
Transcription
1 Disclosures PCOS intervention: On the continous clinical challenge! Sven O. Skouby, MD, DMSc Conflicts of interests: nil Reproductive Medicine Unit Dep. Ob/Gyn. Herlev/Gentofte Hospital, Faculty of Medical and Health Sciences University of Copenhagen, Denmark Learning objectives Learning objectives Prevalence of PCOS: >10% The most prevalent endocrine dysfunction among fertile women Etiology: unknown Apart from ovarian dysfunction clinical penetration of metabolic disturbancies and CVD risk are linked to PCOS phenotypes Intervention therapy may depend on pregnancy wish or solely metabolic or cosmetic problems Often it is a mixture of this triade 3 4 PCOS: Developmental origin Genetic predisposition (Insulin resistance) Prenatal exposure to androgen? Natural history Central obesity Abnormal LH secretion High LH Insulin resistance Hyperandrogenism Anovulation sos/pcos/2012 1
2 23/05/2018 Consensus on women s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group PCOS PCO: Life-time expression a conditioning requiring life long attention? Tekst starter uden Pubertas precox Hirsutism Obesity Irregular bleedings Anovulation Infertility Type-2 DM CVD Cancer 60 yrs 15 yrs Sted og Low birthweight Metabolic disease Reproductive disorders Future health child Future health women Birth Puberty Adolescense Fertile period Senescense Fertility and Sterility, Volume 97, Issue 1, 2012, e25 Enhedens PCOS: Phenotypes are dependent on genetics, epigenitics and enviroment PCOS Tekst starter uden Patophysiology Ovarian dysfunction Sted og 12 Enhedens Rotterdam consensus: Definition of PCOS Hormonal interactions in PCOS Tekst starter uden The Rotterdam criteria 1. Oligo-/amenorrhoea 2. Clinical and/or biochemical hyperandrogenism 3. Polycystic ovaries (PCO) And exclusion of other related disorders Sted og 17 Enhedens Fauser B.C.et el, Hum Repod 2004 Jan;19(1):41-7 2
3 Herlev /Gentofte Ho PCOS phenotypes according to the Rotterdam criteria PCOS and BMI Features Phenotype 1 Phenotype 2 Phenotype 3 Oligo-/amenorrhoea Clinical and/or biochemical hyperandrogenemia Heterogeneity! Phenotype % BMI > 30 Polycystic ovaries PCOS phenotypes translate to different endocrine and metabolic consequences PCOS: Consequenses of IR - However, for most benefical intervention attempts increase in insulin sensitivity seems to be pivotal PCOS: Consequenses of IR 3
4 Herlev Hospital PCOS: CVD in relation to phenotypes Are phenotypes of women with PCOS based on BMI and insulin resistance are more causally associated with distinct CVD risk profiles BMI PCOS: CVD in relation to phenotypes In flammation and thrombosis: ETP and CRP low CRP, Low ETP 70 High CRP, High ETP IR +Obesity +IR +Obesity IR 20 IR Obesity +IR Obesity 10 0 BMI 25-IR BMI 25+IR BMI>25-IR BMI>25+IR The selection of studies included (n=104392) May 22, 2016 Meta-analysis of the association between PCOS and CVD CHD; OR:1.44 P=0,04 MI; OR:1.01 P=0.95 Ovulation disorder PCOS: Treatment 4
5 PCOS Clinical question: Use of OCs in PCOS? Increased thrombosis risk or metabolic benefits? -but no actual pregnancy wish Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism OC s vs metformin Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review Michael F. Costello 1,2,3,6, Bhushan Shrestha 1, John Eden 1, Neil P. Johnson 4 and Peter Sjoblom 5 Change in HOMA-IR values at baseline and 3 months after E2V/DNG treatment. Boxes represent value distribution; vertical lines represent on the bottom the minimum value and on the top the maximum value. Data are presented as medians and IOR. ***p<.001. Vincenzo De Leo, Franca Fruzzetti, Maria Concetta Musacchio, Valeria Scolaro, Alessandra Di Sabatino, Giuseppe Morgante 1 Division of Obstetrics and Gynaecology, School of Women's and Children's Health, University of New South Wales, Royal Hospital for Women, Sydney, NSW, 2031, Australia 2 Department of Reproductive Medicine, Royal Hospital for Women, Sydney, NSW, Australia 3 IVFAustralia, Sydney, NSW, Australia 4 National Women's The Department RCT evidence of Obstetrics and to Gynaecology, date does University of Auckland, Auckland, New Zealand 5 Fertility Centre Scandinavia, Stockholm not show adverse metabolic risk with the use of the OCs compared with metformin Storangsvagen 10, Stockholm, Sweden Human Reproduction : Contraception, Volume 88, Issue 3, 2013,
6 OC s + metformin The available data do not offer enough evidence to advocate the standard use of combined treatment in PCOS Basis of newer drug combinations with OCs? The discovery of melatonin as a direct free radical scavenger has greatly broadened the understanding of melatonin s mechanisms which benefit reproductive physiology 6
7 Glucagonlike peptide-1 (GLP-1) Int J Endocrinol. 2016; 2016: Published online 2016 Oct 23. doi: /2016/ PMCID: PMC PMID: Meal Increases transit time Body weight Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas, and Fabio Facchinetti 1, * 5 1 Department of Medical Sciences, IPUS-Institute of Higher Education, Chiasso, Switzerland 2 Department of Medicine and Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA, USA 3 Clinic of Endocrinology, Alexandrovska University Hospital, Medical University, Sofia, Bulgaria 4 IAKENTRO, Infertility Treatment Center, Thessaloniki, Greece 5 Mother-Infant Department, University of Modena and Reggio Emilia, Modena, Italy *Vittorio Unfer: vunfer@gmail.com Academic Editor: Michael Horowitz Received 2016 Jul 6; Accepted 2016 Sep 22. Blod glucose Decreased Mæthed hunger 47 Herlev og Gentofte Hospital GLP-1 intervention Research M Nylander et al. Liraglutide in PCOS: in effects PCOS: on pro-thrombosis effects on pro-thrombosis : :89 Open Access GLP-1, liraglutide (Victoza ) Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential Malin Nylander 1,2, Signe Frøssing 2,3, Caroline Kistorp 2,3, Jens Faber 2,3 and Sven O Skouby 1,2 1 Department of Obstetrics and Gynecology, Herlev Gentofte Hospital, Herlev, Denmark 2 Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark 3 Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark Correspondence should be addressed to M Nylander machny@dadlnet.dk 5/23/18 48 Liraglutide and PCOS Intervention with GLP-1 analog in overweight PCOS women Improved bleeding pattern, Increased SHBG CONCLUSION Decreased deposition of perihepatic fat mass No effects on markers of endothelial dysfunction or low-grade inflammation Conclusion: PCOS intervention Promising basis for use of new drugs: Yes -combined with OCs? Jury is still out! 7
8 THANK YOU! 8
Herlev/Gentofte Hospital. Fauser B.C. et al, Fertil Steril 2012 Jan ;97(1): Fau ser B.C.et el, Hu m Repod Jan;19 (1 ):41-7
Learning objectives PCOS intervention according to phenotypes and Co-morbidity Sven O. Skouby, Professor, MD, DSc Director of Endocrinology and Reproductive Sciences Dep. Ob/Gyn., Faculty of Health Scie
More informationPolycystic Ovary Syndrome (PCOS):
Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,
More informationInternational Evidence-based Guideline on the Assessment and Management of PCOS 2018: PCOS 2018 Guideline Explained.
International Evidence-based Guideline on the Assessment and Management of PCOS 2018: PCOS 2018 Guideline Explained Michael Costello IVF Australia University of New South Wales (UNSW) Royal Hospital for
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationNew PCOS guidelines: What s relevant to general practice
New PCOS guidelines: What s relevant to general practice Dr Michael Costello Fertility Specialist IVF Australia UNSW Royal Hospital for Women Sydney How do we know if something is new? Louvre Museum, Paris
More informationPrevalence of polycystic ovarian syndrome in the Buraimi region of Oman
Original Article Brunei Int Med J. 2012; 8 (5): 248-252 Prevalence of polycystic ovarian syndrome in the Buraimi region of Oman Usha VARGHESE 1 and Shaji VARUGHESE 2, 1 Department of Internal Medicine
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More information3. Metformin therapy for PCOS
1. Introduction The key clinical features of polycystic ovary syndrome (PCOS) are hyperandrogenism (hirsutism, acne, alopecia) and menstrual irregularity with associated anovulatory infertility. 1 The
More informationCREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University
CREATING A PCOS TREATMENT PLAN Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University PCOS: CREATING A TREATMENT PLAN Good treatment plans are based on sound and complete evaluations History of
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea
More informationPolycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology
Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about
More informationAmenorrhoea: polycystic ovary syndrome
There is so much we don't know in medicine that could make a difference, and often we focus on the big things, and the little things get forgotten. To highlight some smaller but important issues, we've
More informationPCOS and Obesity DUB is better treated by OCPs
PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationS. AMH in PCOS Research Insights beyond a Diagnostic Marker
S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.
More informationStudy of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population
Original article: Study of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population 1Dr Shalini Kanotra, 2 Dr Nikita Singh*, 3 Dr V B Bangal 1 Associate Professor, OBGY Department,
More informationTitle of Guideline (must include the word Guideline (not protocol, policy, procedure etc)
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guideline for the Investigation and Management of Polycystic Ovary Syndrome Author: Contact Name and Job Title
More informationMetformin in early pregnancy and abortions. Laure Morin-Papunen, MD, PhD Dept. of Obstetrics and Gynecology University Hospital of Oulu, Finland
Metformin in early pregnancy and abortions Laure Morin-Papunen, MD, PhD Dept. of Obstetrics and Gynecology University Hospital of Oulu, Finland PCOS and miscarriage risk Metformin and miscarriage risk
More informationReproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD)
Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD) Pr Sophie Christin-Maitre Reproductive Endocrine Unit, Hôpital Saint-Antoine, AP-HP Université Pierre et Marie Curie INSERM U933 Paris, France
More informationRiju Angik*, Shubhada S. Jajoo, C. Hariharan, Amogh Chimote
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Angik R et al. Int J Reprod Contracept Obstet Gynecol. 2015 Feb;4(1):189-194 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationFemale androgen profiles by MS for PCOS patients. CS Ho APCCMS 2010, Hong Kong 14 January 2010
Female androgen profiles by MS for PCOS patients CS Ho APCCMS 2010, Hong Kong 14 January 2010 873 women with increased serum androgens Androgen-secreting neoplasms 0.2% Classical CAH 0.6% Non-classical
More informationPolycystic Ovary Disease: A Common Endocrine Disorder in Women
Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More informationPregnancy outcome in women with polycystic ovary syndrome
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nivedhitha VS et al. Int J Reprod Contracept Obstet Gynecol. 2015 Aug;4(4):1169-1175 www.ijrcog.org pissn 2320-1770 eissn
More informationPCOS. Reproductive Gynaecology and Infertility. Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University
Reproductive Gynaecology and Infertility PCOS Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University Dr.Hussein Sabban MD. FRCSC PGY6 GREI Dalhousie University Disclosure No conflict of interest Pilot
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome What is Polycystic Ovarian Syndrome? Polycystic Ovarian Syndrome (PCOS) is characterized by the presence of multiple ovarian cysts and excess androgen production. Clinical Features
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationPolycystic Ovarian Syndrome (PCOS) LOGO
Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction
More informationPolycystic Ovary Syndrome
What is the polycystic ovary syndrome? Polycystic Ovary Syndrome The polycystic ovary syndrome (PCOS) is a clinical diagnosis characterized by the presence of two or more of the following features: irregular
More informationCase Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation
Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine
More informationPCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS
PCOS Awareness Symposium Atlanta September 24 th, 2016 Preventing Diabetes & Cardiovascular Disease in PCOS Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Kathleen Colleran, MD Professor of Medicine University of New Mexico HSC Presented for COMM-TC May 4, 2012 Objectives Understand the pathophysiology of PCOS Understand how to
More informationNitasha Garg 1 Harkiran Kaur Khaira. About the Author
https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using
More informationDetermining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)
Abstract: Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs) Ashraf Olabi, Ghena Alqotini College of medicine, Aleppo University Hospital Obstetrics and Gynacology, Syria.
More informationInfertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
Macut D, Pfeifer M, Yildiz BO, Diamanti-Kandarakis E (eds): Polycystic Ovary Syndrome. Novel Insights into Causes Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications
More informationCan Sex hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome?
www.ijpm.in www.ijpm.ir Can Sex hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome? Ferdous Mehrabian, Maryam Afghahi Department
More informationPrevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai
Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji
More informationWHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED
WHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED Ricardo Azziz, M.D., M.P.H., M.B.A. Chief Officer of Academic Health & Hospital Affairs State University of New York (SUNY)
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationIMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS
IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS Kedikova S. MD, PhD Medical University Sofia, Bulgaria University Hospital Maichin dom Sofia NUTRITION WHO - Nutrition is the intake of
More informationPolycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG
Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG What is an ovulatory dysfunction? Mrs. Susana Godoy, Nurse-Midwife San José, Costa Rica Abril 2018 PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE
More informationSCREENING OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT GIRLS AT CAIRO UNIVERSITY
SCREENING OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT GIRLS AT CAIRO UNIVERSITY Sahar Mansour Ibrahim, Yossria Ahmed Elsayed, Reda Esmail Reyad 4 and Hanan Fahmy Azzam 1* 2 3 1 Assistant Lecturer,
More informationUPDATE: Women s Health Issues
UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial
More informationPolycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan
Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Life-long condition Hirsutism Menstrual irregularities? Pronounced
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationReproductive outcome in women with body weight disturbances
Reproductive outcome in women with body weight disturbances Zeev Shoham M.D. Dep. Of OB/GYN Kaplan Hospital, Rehovot, Israel Weight Status BMI (kg/m 2 ) Underweight
More informationWhat every dermatologist should know about Polycystic Ovary Syndrome (PCOS)
What every dermatologist should know about Polycystic Ovary Syndrome (PCOS) Kanade Shinkai, MD PhD University of California, San Francisco Associate Professor of Dermatology I have no conflicts of interest
More informationPolycystic Ovary Syndrome (PCOS)
Mr Nabil Haddad M. OBSTET, GYNAEC, FRCOG Consultant Gynaecologist Patient Information Polycystic Ovary Syndrome (PCOS) Mr Nabil Haddad Consultant Gynaecologist What is Polycystic Ovary Syndrome (PCOS)?
More informationCam type Femoroacetabular Impingement associated with Marker for Hyperandrogenism in Women
Cam type Femoroacetabular Impingement associated with Marker for Hyperandrogenism in Women Andrew B. Wolff, MD a Torie Plowden, MD b Alexandra Napoli, BA a Benjamin McArthur, MD a Erin F. Wolff, MD b a
More informationScope. Update and expansion of Evidence-based guideline for the assessment and management of PCOS. Clinical context
Scope Update and expansion of Evidence-based guideline for the assessment and management of PCOS Clinical context Polycystic ovary syndrome (PCOS) is a significant public health issue with reproductive,
More informationUpdate on PCOS Research. Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA
Update on PCOS Research Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Conflicts Consultant: Euroscreen, AstraZeneca, Ferring, Clarus, Kindex, Takeda Funding:
More informationPOLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015
POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility Based on: ACOG No. 108 Oct 2009; reaffirmed 2015 NO DISCLOSURES PATIENT 26 years old presents with complaint of
More informationComparative study of metabolic profile of women presenting with polycystic ovary syndrome in relation to body mass index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Akshaya S et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2561-2565 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationThe Impact of Insulin Resistance on Long-Term Health in PCOS
Saturday, April 16 th, 2016 PCOS Challenge & Thomas Jefferson University PCOS Awareness Symposium Philadelphia The Impact of Insulin Resistance on Long-Term Health in PCOS Katherine Sherif, MD Professor
More informationDiabetic Medicine. Myo-inositol may prevent gestational diabetes in PCOS women. Preliminary data.
Myo-inositol may prevent gestational diabetes in PCOS women. Preliminary data. Journal: Diabetic Medicine Manuscript ID: DME--00 Manuscript Type: Short Report Date Submitted by the Author: -May- Complete
More informationHyperandrogenism, PCOS and obesity after menopause : Meet the experts. Polycystic ovaries beyond menopause
Hyperandrogenism, PCOS and obesity after menopause : Meet the experts Polycystic ovaries beyond menopause Serge Rozenberg CHU St Pierre Université libre de Bruxelles, Vrije Universiteit Brussel Belgium
More informationBernd Lesoine 1 and Pedro-Antonio Regidor Introduction
Hindawi Publishing Corporation International Journal of Endocrinology Volume 216, Article ID 437857, 5 pages http://dx.doi.org/1.1155/216/437857 Clinical Study Prospective Randomized Study on the Influence
More informationJMSCR Vol 05 Issue 05 Page May 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i5.14 Hyperinsulinemia in Polycystic Ovary Syndrome
More informationInositols for PCOS : An Update. Mark H. Ratner, MD Shady Grove Reproductive Science Center Rockville, Maryland
Inositols for PCOS : An Update Mark H. Ratner, MD Shady Grove Reproductive Science Center Rockville, Maryland Overview Understanding the role of insulin in PCOS The relationship between inositols and insulin
More information13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH
13 th Annual Women s Health Day PCOS Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH Learning objectives Perform the appropriate investigations in women where there is a clinical suspicion
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationFemale Reproductive Endocrinology
Female Reproductive Endocrinology Dr. Channa Jayasena PhD MRCP FRCPath Clinical Senior Lecturer & Consultant Endocrinologist Department of Gynaecology, Hammersmith Hospital Anovulation is a common cause
More informationMetfornim and Pioglitazone in polycystic ovarian syndrome: A comparative study
Original Research Article Metfornim and Pioglitazone in polycystic ovarian syndrome: A comparative study Allanki Suneetha Devi 1, Jalem Anuradha 2* 1 Associate Professor, Department of Obstetrics and Gynecology,
More informationPCOS. pregnancy complications. Prof. Bart CJM Fauser. Dept. Reproductive Medicine and Gynecology. University Medical Center, Utrecht, The Netherlands
PCOS pregnancy complications Prof. Bart CJM Fauser Dept. Reproductive Medicine and Gynecology University Medical Center, Utrecht, The Netherlands Disclosure of interest, Fauser Professor of Reproductive
More informationPCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION
PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION R A C H A N A S H A H, M D M S T R A S S I S TA N T P R O F E S S O R O F P E D I AT R I C S D I V I S I O N O F E N D O C R I N O L O G Y A N D D
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationPCOS & Diet Therapy. Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015
PCOS & Diet Therapy Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015 Questions to be discussed: 1) Why dietary modification is considered as first line of treatment? 2) What
More informationRole of inositol in Reproductive Function
Role of inositol in Reproductive Function Dr. Mirudhubashini Govindarajan, FRCSC Clinical Director Womens Center Coimbatore HYPE OR HOPE???? Inositol an Introduction Inositol has 10 types of isomers Myo
More informationPCOS-Understanding the Science and Practice. Inositols. Maurizio Nordio, University Sapienza, Rome, Italy Mumbai, June 18th, 2016
PCOS-Understanding the Science and Practice Inositols Maurizio Nordio, University Sapienza, Rome, Italy Mumbai, June 18th, 2016 maurizionordio1@gmail.com PCOS and insulin It is well known that a strong
More informationThe prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria
Prace oryginalne/original papers Endokrynologia Polska/Polish Journal of Endocrinology Tom/Volume 62; Numer/Number 3/2011 ISSN 0423 104X The prevalence of polycystic ovary syndrome in Iranian women based
More informationWhat is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...
PCOS What is PCOS? You'll be amazed when you read this... What is PCOS?. Who is at risk? How to get tested? What are the complications. Is there a cure? What are the right ways to eat? What lifestyle changes
More informationPCOS What s new in Diagnosis & Treatment?
PCOS What s new in Diagnosis & Treatment? Roy Homburg Maccabi Medical Services and Barzilai Medical Centre, Ashkelon, Israel. Antalya, October, 2009 PCOS diagnosis - 1990 NIH criteria - Hyperandrogenism
More informationRotterdam Criteria 9/30/2017. A Changing Paradigm in PCOS. Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause?
Disclosure Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause? Fractyl laboratories, Inc Anuja Dokras, MD., Ph.D. Professor of Obstetrics and Gynecology Director PENN PCOS
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationInternational Journal of Clinical Endocrinology and Metabolism. Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome
v Clinical Group International Journal of Clinical Endocrinology and Metabolism DOI CC By Rim Hanna 1 *, Tarek Wehbe 2 and Elizabeth Abou Jaoude 3 1 The Holy Spirit University of Kaslik, Faculty of Agricultural
More informationClinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
POLYCYSTIC OVARY SYNDROME Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes Ettore Guastella, M.D., a Rosa Alba Longo, M.D., b and Enrico Carmina, M.D. b a Department
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationCORRELATION OF OBESITY, INSULIN RESISTANCE AND LIPID PROFILE IN WOMEN WITH PCOS IN KIMS HOSPITAL BANGALORE Shashikala H. Gowda 1, Mansi Dhingra 2
CORRELATION OF OBESITY, INSULIN RESISTANCE AND LIPID PROFILE IN WOMEN WITH PCOS IN KIMS HOSPITAL BANGALORE Shashikala H. Gowda 1, Mansi Dhingra 2 HOW TO CITE THIS ARTICLE: Shashikala H. Gowda, Mansi Dhingra.
More informationResearch Article Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study
International Endocrinology Volume 2016, Article ID 9537632, 5 pages http://dx.doi.org/10.1155/2016/9537632 Research Article Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile
More informationPolycystic Ovary Syndrome
Page 1 of 5 Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is common. It can cause period problems, reduced fertility, excess hair growth, and acne. Many women with PCOS are also overweight.
More informationReview Article Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
International Journal of Endocrinology Volume 2016, Article ID 1849162, 12 pages http://dx.doi.org/10.1155/2016/1849162 Review Article Effects of Inositol(s) in Women with PCOS: A Systematic Review of
More informationOriginal Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?
Chettinad Health City Medical Journal Original Article Puvithra T*, Radha Pandiyan**, Pandiyan N*** *Assistant Professor, **Senior Consultant & Associate Professor, ***Prof & HOD, Department of Andrology
More informationMetabolic changes in menopausal transition
Metabolic changes in menopausal transition Terhi T. Piltonen M.D., Associate Professor Consultant, Clinical Researcher for the Finnish Medical Foundation Department of Obstetrics and Gynecology PEDEGO
More information12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND
Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND 7% of all women 18-45 Obesity 1/3 of all US women Incidence of PCOS is increasing with increase obesity Obesity Irregular
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationInfertility for the Primary Care Provider
Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have
More informationPCOS guidelines: What s relevant to general practice
PCOS guidelines: What s relevant to general Dr David Molloy Medical Director, Queensland Fertility Group International evidence based PCOS guidelines 1st ever internationally endorsed & evidence based
More informationClinical Study Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS
International Endocrinology Volume 2012, Article ID 434830, 5 pages doi:10.1155/2012/434830 Clinical Study Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS Kim Forrester-Dumont,
More informationGonadotrophin treatment in patients with Polycystic Ovary Syndrome
Int. J. Adv. Res. Biol. Sci. (218). 5(4): 95-99 International Journal of Advanced Research in Biological Sciences ISSN: 2348-869 www.ijarbs.com DOI: 1.22192/ijarbs Coden: IJARQG(USA) Volume 5, Issue 4-218
More informationPolycystic ovary syndrome (PCOS)
Information for patients Polycystic ovary syndrome (PCOS) What is polycystic ovary syndrome? Polycystic ovary syndrome (PCOS) is a condition which can affect a woman s menstrual cycle, fertility, hormones
More informationPrevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study
Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study Mousa Mohsen Ali* Wasan Ghazi* HayderAamerAbboud^ *Kerbala University, College of Medicine, Gynecology
More informationA study of N-acetyl cysteine, metformin and vitamin D3 with calcium on clinical and metabolic profile in PCOS
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Gupta V et al. Int J Reprod Contracept Obstet Gynecol. 2017 Oct;6(10):4372-4376 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174407
More informationAddressing Practice Gaps in PCOS
Addressing Practice Gaps in PCOS PCOS Challenge September 21, 2014 Ricardo Azziz, MD, MPH, MBA President, Georgia Regents University CEO, Georgia Regents Health System Introduction PCOS research began
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Study on Assessment of Testosterone, Insulin Resistance and HbA1c in Women with Polycystic
More informationAssisted Reproductive. Technologies: Present and. Future
Assisted Reproductive Technologies: Present and Future Paul Kaplan, M.D. The Assisted Reproductive Technologies (ART) In Vitro Fertilization (IVF) Intracytoplasmic Sperm Injection (IVF/ICSI) Donor Oocyte
More informationWhat is PCOS? Key Points. Definition. Key Signs + Symptoms. Typical Experiences 10/29/2017
Polycystic Ovarian Syndrome, Binge Eating Disorder, and Weight Bias Applying Weight Inclusive Approaches Rather Than Weight Normative Approaches Promotes Long Term Physical and Emotional Health Julie Duffy
More informationInvestigation of adrenal functions in patients with idiopathic hyperandrogenemia
European Journal of Endocrinology (26) 155 37 311 ISSN 84-4643 CLINICAL STUDY Investigation of adrenal functions in patients with idiopathic hyperandrogenemia Hulusi Atmaca, Fatih Tanriverdi 1, Kursad
More informationJannet Huang, MD, FRCPC, FACE, ABIHM, CCD, NCMP.
Jannet Huang, MD, FRCPC, FACE, ABIHM, CCD, NCMP. Polycystic Ovarian Syndrome Definition & Diagnosis Clinical Significance: Link to Diabetes and Cardiovascular Risk Management Lifestyle Strategies Pharmacologic
More informationPhenotypes in Male & Female First Degree Relatives of Women with PCOS. Andrea Dunaif, MD
Phenotypes in Male & Female First Degree Relatives of Women with PCOS Andrea Dunaif, MD 1 ~7% Prevalence Anovulatory PCOS Leading Cause Hormonally-Related Infertility 4-Fold Increased Risk Type 2 Diabetes
More information